Literature DB >> 2431962

Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival.

D L Clarke-Pearson, N O Chin, E R DeLong, R Rice, W T Creasman.   

Abstract

The results of surgery to relieve intestinal obstruction in 49 patients who were known to have ovarian cancer were studied. All patients had received adjunctive chemotherapy and/or radiation therapy prior to bowel obstruction. Thirty patients had small bowel obstruction, 16 patients had colonic obstruction, and 3 patients had concurrent small and large bowel obstruction. Clinical status, nutritional parameters, and radiographic findings were analyzed. Progressive ovarian cancer was ultimately found to be the cause of obstruction in 86% of patients. Major postoperative complications occurred in 49% of patients and were encountered significantly more frequently in those patients with small bowel obstruction (P less than 0.04). Complications most frequently encountered included wound infection, enterocutaneous fistulae, and other septic sequelae. Median postoperative survival was 140 days, with 73% surviving at 60 days postoperatively. A total of 14.3% of patients were alive 12 months postoperatively. These results are similar to prior reports and emphasize the need for clearer preoperative selection criteria.

Entities:  

Mesh:

Year:  1987        PMID: 2431962     DOI: 10.1016/0090-8258(87)90066-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

Review 1.  Salvage therapy for ovarian cancer.

Authors:  A A Garcia
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

Review 2.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

Review 3.  Management of opioid-induced bowel dysfunction in cancer patients.

Authors:  Antonio Cesar Tamayo; Paola Andrea Diaz-Zuluaga
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

4.  Bowel obstruction in elderly ovarian cancer patients: a population-based study.

Authors:  Stephen J Mooney; Megan Winner; Dawn L Hershman; Jason D Wright; Daniel L Feingold; John D Allendorf; Alfred I Neugut
Journal:  Gynecol Oncol       Date:  2012-12-26       Impact factor: 5.482

Review 5.  Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  Sarah E Cousins; Emma Tempest; David J Feuer
Journal:  Cochrane Database Syst Rev       Date:  2016-01-04

Review 6.  The role of palliative surgery in gynecologic cancer cases.

Authors:  Joanie Mayer Hope; Bhavana Pothuri
Journal:  Oncologist       Date:  2013-01-08

Review 7.  Palliative surgery versus medical management for bowel obstruction in ovarian cancer.

Authors:  Ali Kucukmetin; Raj Naik; Khadra Galaal; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

8.  Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

Authors:  A C Okaro; D A Fennell; M Corbo; B R Davidson; F E Cotter
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study.

Authors:  Megan Winner; Stephen J Mooney; Dawn L Hershman; Daniel L Feingold; John D Allendorf; Jason D Wright; Alfred I Neugut
Journal:  Dis Colon Rectum       Date:  2013-07       Impact factor: 4.585

Review 10.  Recent advances in malignant bowel obstruction: an interface of old and new.

Authors:  Vinaya Potluri; Donna S Zhukovsky
Journal:  Curr Pain Headache Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.